Accutane (Isotretinoin) Blood Test Monitoring: What You Need

Isotretinoin — known by the brand name Accutane (or Roaccutane in the UK) — is the most effective treatment for severe and treatment-resistant acne. It works by dramatically reducing sebum production, shrinking sebaceous glands, and normalising skin cell turnover. It also requires careful blood test monitoring throughout treatment, and there are good reasons why dermatologists insist on it.

Why blood tests are mandatory on isotretinoin

Isotretinoin is a retinoid derived from vitamin A, and at therapeutic doses (0.5–1.0 mg/kg/day) it places measurable stress on the liver and lipid metabolism. The British Association of Dermatologists (BAD) and NICE both require baseline blood tests before starting treatment and regular monitoring throughout — typically monthly for the first 3 months and then every 1–3 months depending on results.

The purpose is not to discourage treatment — isotretinoin is genuinely transformative for severe acne — but to catch adverse effects early, before they cause lasting damage. Most side effects are dose-dependent and reversible if identified promptly.

The mandatory markers

Liver function tests (LFTs)

Isotretinoin is hepatotoxic. It is metabolised by the liver, and at standard doses it can elevate liver enzymes in approximately 10–15% of patients. The critical markers are:

• ALT (alanine aminotransferase): The most liver-specific enzyme. Normal range is below 35 U/L for women and below 41 U/L for men. Mild elevations (up to 2x the upper limit) are common and often tolerated with dose monitoring. Elevations above 3x the upper limit typically require dose reduction or cessation.
• AST (aspartate aminotransferase): Less liver-specific than ALT (also found in muscle and heart) but part of the standard panel. Normal range is 10–40 U/L.
• GGT (gamma-glutamyl transferase): Rises with hepatic stress, alcohol use and cholestatic conditions. Often the earliest marker to elevate.
• ALP (alkaline phosphatase) and bilirubin: Complete the picture. Elevated bilirubin with elevated ALT suggests more significant hepatocellular damage.

Alcohol consumption while on isotretinoin compounds hepatic stress. Dermatologists typically advise minimising or abstaining from alcohol during treatment — and the liver function tests will show why if you do not.

Lipid panel

Isotretinoin commonly elevates blood lipids, and triglycerides are the most affected marker. Studies consistently show triglyceride increases of 30–50% from baseline during treatment, with some patients experiencing spikes above 5.0 mmol/L (normal is below 1.7 mmol/L). Severely elevated triglycerides carry a risk of acute pancreatitis — a medical emergency.

The full lipid panel should include:

• Triglycerides: The priority marker. Below 1.7 mmol/L is normal; 1.7–2.3 is borderline; above 2.3 warrants close monitoring; above 5.0 requires dose reduction or cessation.
• Total cholesterol: Often rises 10–20% during treatment. Desirable level is below 5.0 mmol/L.
• LDL cholesterol: May increase. Below 3.0 mmol/L is optimal.
• HDL cholesterol: Isotretinoin can reduce HDL, worsening the overall lipid ratio.

If your lipids were already borderline before starting isotretinoin, close monitoring is essential. Patients with a family history of hyperlipidaemia or cardiovascular disease should have lipids checked monthly throughout treatment.

Full blood count (FBC)

Isotretinoin can affect blood cell counts, though significant changes are uncommon. White blood cell count, platelet count and haemoglobin should be monitored. A falling platelet count or white cell count warrants investigation.

Pregnancy test (women of childbearing age)

Isotretinoin is one of the most potent known teratogens. Exposure during pregnancy causes severe birth defects in over 35% of exposed pregnancies, including craniofacial, cardiac and central nervous system malformations. The Pregnancy Prevention Programme (PPP) requires:

• A negative pregnancy test before each prescription
• Two forms of contraception throughout treatment and for one month after stopping
• Monthly pregnancy tests during treatment

This is a non-negotiable regulatory requirement in the UK, overseen by the MHRA.

Additional markers worth checking

Dermatologists often order only the minimum — LFTs, lipids, FBC and pregnancy test. A broader panel catches things the standard monitoring misses:

• Vitamin D: Isotretinoin and vitamin A metabolism interact with vitamin D pathways. Many acne patients are already vitamin D deficient (low vitamin D has been linked to acne severity), and monitoring ensures levels are maintained during treatment.
• Kidney function (creatinine, eGFR, urea): While isotretinoin is primarily hepatically metabolised, kidney function affects overall drug clearance. Baseline and periodic checks are prudent, particularly for longer treatment courses.
• CRP (C-reactive protein): Some patients develop isotretinoin-related musculoskeletal symptoms (joint pain, myalgia). CRP can help distinguish between drug-related inflammation and other causes.

Monitoring schedule

The recommended timeline for blood tests during isotretinoin treatment:

• Baseline (before starting): Full panel — LFTs, lipids, FBC, kidney function, vitamin D. This establishes your pre-treatment values against which all future results are compared.
• Month 1: LFTs, lipids, FBC. The first month often shows the most dramatic changes as the body adjusts to the drug.
• Month 2: LFTs, lipids, FBC. Confirm that month 1 changes have stabilised rather than progressed.
• Month 3 and beyond: LFTs, lipids, FBC. If results have been stable through months 1 and 2, many dermatologists extend to every 2–3 months. If triglycerides or ALT were elevated, monthly monitoring continues.
• End of treatment: Full panel including vitamin D and kidney function. Confirm everything is returning to baseline.

Recommended Lola Health tests

Rather than relying solely on the limited panel your dermatologist orders, consider adding broader coverage:

• Liver & Kidney Function — £81 — Covers ALT, AST, GGT, ALP, bilirubin, albumin, creatinine, eGFR and urea. The essential liver and kidney markers for isotretinoin monitoring in a single, affordable panel.
• Cardiovascular Health — £83 — Full lipid panel including total cholesterol, LDL, HDL, triglycerides and non-HDL cholesterol, plus cardiovascular inflammation markers. Directly addresses the lipid monitoring isotretinoin requires.
• Core Health 45 — £120 — Combines liver function, kidney function, lipids, vitamin D, full blood count and more in a 45-biomarker panel. The most efficient option if you want comprehensive monitoring in a single test — covers everything your dermatologist checks plus the markers they typically miss.

What to do if results are abnormal

Mild elevations in ALT (up to 2x upper limit) and triglycerides (up to 2.3 mmol/L) are common and usually managed by monitoring and dietary adjustments — reducing alcohol, refined carbohydrates and saturated fats. If ALT exceeds 3x the upper limit or triglycerides exceed 5.0 mmol/L, your dermatologist will typically reduce the isotretinoin dose or pause treatment temporarily.

Share your results with your prescribing dermatologist. Private blood tests are a complement to, not a replacement for, the clinical monitoring your dermatologist provides. The advantage of testing through Lola Health is broader coverage, faster turnaround and the ability to track your results over time in one place — particularly useful during a treatment that requires regular monitoring over 5–8 months.

The bottom line

Isotretinoin is a powerful, effective medication that demands respect. Blood test monitoring is not optional — it is the safety net that allows you to use the drug confidently. A baseline panel before starting, monthly checks during treatment, and a final panel after completion ensure that your liver, lipids and blood counts remain within safe limits throughout. The investment in regular testing is small compared with the consequences of undetected hepatotoxicity or severe hypertriglyceridaemia.